Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 31.4190.4644.6521.42-16.64

What is the latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS is 31.41 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202431.41
Mar202390.46
Mar202244.65
Mar202121.42
Mar2020-16.64

How is Core EBITDA Growth of FREDUN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 31.41
-65.28
Mar2023 90.46
102.60
Mar2022 44.65
108.45
Mar2021 21.42
Positive
Mar2020 -16.64 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹314.4 Cr 5.6% 5.9% -18.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,293.0 Cr -1.5% 9.1% 9.1% Stock Analytics
DIVIS LABORATORIES ₹139,692.0 Cr -4.9% -0.6% 59.1% Stock Analytics
CIPLA ₹111,807.0 Cr -1.8% 1% 0.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,404.0 Cr 1.6% 12.1% 21.8% Stock Analytics
DR REDDYS LABORATORIES ₹90,843.0 Cr -3% -0.9% -7.7% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

5.6%

5.9%

-18.1%

SENSEX

-5.5%

0.2%

-1%


You may also like the below Video Courses